FIELD: medicine, pharmacology.
SUBSTANCE: the present innovation deals with preparation for treating and preventing inspecific ulcerous colitis that contains N-(2-ethylsulfonylamino-5-trifluoromethyl-3-pyridyl) cyclohexane carboxamide or its salt.
EFFECT: increased activity of preparation suggested.
1 cl, 2 ex, 2 tbl
Authors
Dates
2005-12-20—Published
2001-01-30—Filed